Matsumoto, Tomonori <br/><br/>
Adalimumab-induced lethal hepatitis B virus reactivation in an HBsAg-negative patient with clinically resolved hepatitis B virus infection.  [electronic resource] 

 -  Liver international : official journal of the International Association for the Study of the Liver  Sep 2010 
 - 1241-2 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1478-3231 
<br/><br/><label>Standard No.: </label>10.1111/j.1478-3231.2010.02238.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Aged<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Arthritis, Rheumatoid--drug therapy<br/>Fatal Outcome<br/>Female<br/>Hepatitis B Surface Antigens<br/>Hepatitis B virus--drug effects<br/>Humans<br/>Liver--pathology<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Virus Activation--drug effects